Please find enclosed monitoring agency report for quarter ended June 30, 2026.

August 04, 2026 To, To, National Stock Exchange of India Limited (“NSE”)BSE Limited (“BSE”) Listing Department Listing Department Exchange Plaza, C-1 Block G, Bandra Kurla Complex Corporate Relationship Department Bandra [E], Mumbai – 400051 Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai - 400 001 NSE Scrip Symbol: EPACKPEB BSE Scrip Code: 544540 ISIN: INE0MLS01022 ISIN: INE0MLS01022 Sub: Disclosure under Regulation 32(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015 - Submission of Monitoring Agency Report Dear Sir/ Madam, Pursuant to Regulation 32(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Regulation 41(4) of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, please find enclosed herewith Monitoring Agency Report in respect of the utilization of proceeds of Initial Public Offer, for the Quarter ended June 30, 2026, issued by CARE Ratings Limited, Monitoring Agency. The above information will also be hosted on the website of the company i.e. https://epackprefab.com/investor-relations/. Kindly take the same on record. Thanking You, For EPACK PREFAB TECHNOLOGIES LIMITED (Formerly known as EPACK Prefab Technologies Private Limited and EPACK Polymers Private Limited) Preeti Chauhan Company Secretary and Compliance Officer Place: Noida Encl.: As above No. CARE/NRO/GEN/2026-27/1082 The Board of Directors Epack Prefab Technologies Limited 61-B, Udyog Vihar Surajpur, Kasna Road, Gautam Buddha Nagar, Greater Noida, Uttar Pradesh, India - 201306 August 3, 2026 Dear Sir/Ma’am, Monitoring Agency Report for the quarter ended June 30, 2026 - in relation to the IPO of Epack Prefab Technologies Limited (“the Company”) We write in our capacity of Monitoring Agency for the IPO for the amount aggregating to Rs. 300 crores of the Company and refer to our duties cast under 41 of the Securities & Exchange Board of India (Issue of Capital & Disclosure Requirements) Regulations. In this connection, we are enclosing the Monitoring Agency Report for the quarter ended June 30, 2026 as per aforesaid SEBI Regulations and Monitoring Agency Agreement dated September 15, 2025. Request you to kindly take the same on records. Thanking you, Yours faithfully, Sahil Goyal Associate Director Sahil.goyal@careedge.in CARE Ratings Limited 9th floor, C-001/A2, Berger Towers, Sector 16B, Noida, 4th Floor, Godrej Coliseum, Somaiya Hospital Road, Off Gautam Budh Nagar, Uttar Pradesh -201301 Eastern Express Highway, Sion (East), Mumbai - 400 022 Phone: +91-120-4452000 Phone: +91-22-6754 3456 Email: care@careedge.in • www.careedge.in CIN-L67190MH1993PLC071691 Report of the Monitoring Agency Name of the issuer: Epack Prefab Technologies Limited For quarter ended: June 30, 2026 Name of the Monitoring Agency: CARE Ratings Limited (a) Deviation from the objects: No deviation (Refer note below) (b) Range of Deviation: NA Note: During Q1FY27, the company utilized Rs. 21.44 crores, of which Rs. 6.49 crores were utilized from the current account. There has been a comingling of funds (where issue proceeds were mixed with other cash flows) owing to usage from current account. Such comingling of funds was observed in the report for Q3FY26 and Q4FY26 as well. We have relied on the Management Certificate and CA certificate dated July 28, 2026 from Talati and Talati LLP, for verifying the utilizations and the nature of the aforesaid unverified transactions during Q1FY27. Further, in Q3FY26. the unutilized amount was transferred by the company from its monitoring account to current account, from where, fixed deposits with varied maturity dates were created. Some of these fixed deposits are still outstanding, as detailed in section 4(iv) of the report. Declaration: We declare that this report provides an objective view of the utilization of the issue proceeds in relation to the objects of the issue based on the information provided by the Issuer and information obtained from sources believed by it to be accurate and reliable. The MA does not perform an audit and undertakes no independent verification of any information/ certifications/ statements it receives. This Report is not intended to create any legally binding obligations on the MA which accepts no responsibility, whatsoever, for loss or damage from the use of the said information. The views and opinions expressed herein do not constitute the opinion of MA to deal in any security of the Issuer in any manner whatsoever. Nothing mentioned in this report is intended to or should be construed as creating a fiduciary relationship between the MA and any issuer or between the agency and any user of this report. The MA and its affiliates also do not act as an expert as defined under Section 2(38) of the Companies Act, 2013. The MA or its affiliates may have credit rating or other commercial transactions with the entity to which the report pertains and may receive separate compensation for its ratings and certain credit related analyses. We confirm that there is no conflict of interest in such relationship/interest while monitoring and reporting the utilization of the issue proceeds by the issuer, or while undertaking credit rating or other commercial transactions with the entity. We have submitted the report herewith in line with the format prescribed by SEBI, capturing our comments, where applicable. There are certain sections of the report under the title “Comments of the Board of Directors”, that shall be captured by the Issuer’s Management / Audit Committee of the Board of Directors subsequent to the MA submitting their report to the issuer and before dissemination of the report through stock exchanges. These sections have not been reviewed by the MA, and the MA takes no responsibility for such comments of the issuer’s Management/Board. CARE Ratings Limited 9th floor, C-001/A2, Berger Towers, Sector 16B, Noida, 4th Floor, Godrej Coliseum, Somaiya Hospital Road, Off Gautam Budh Nagar, Uttar Pradesh -201301 Eastern Express Highway, Sion (East), Mumbai - 400 022 Phone: +91-120-4452000 Phone: +91-22-6754 3456 Email: care@careedge.in • www.careedge.in CIN-L67190MH1993PLC071691 Signature: Name and designation of the Authorized Signatory: Sahil Goyal Designation of Authorized person/Signing Authority: Associate Director CARE Ratings Limited 9th floor, C-001/A2, Berger Towers, Sector 16B, Noida, 4th Floor, Godrej Coliseum, Somaiya Hospital Road, Off Gautam Budh Nagar, Uttar Pradesh -201301 Eastern Express Highway, Sion (East), Mumbai - 400 022 Phone: +91-120-4452000 Phone: +91-22-6754 3456 Email: care@careedge.in • www.careedge.in CIN-L67190MH1993PLC071691 1) Issuer Details: Name of the issuer : Epack Prefab Technologies Limited Name of the promoter : Singhania and Bothra families Industry/sector to which it belongs : Other Manufacturing 2) Issue Details Issue Period : September 24, 2025 to September 26, 2025 Type of issue (public/rights) : IPO Type of specified securities : Equity shares IPO Grading, if any : NA Issue size (in crore) : Rs. 300 crore 3) Details of the arrangement made to ensure the monitoring of issue proceeds: Source of information / certifications Comments of the Comments of the Particulars Reply considered by Monitoring Agency for Board of Monitoring Agency preparation of report Directors During Q1FY27, the company utilized Rs. 21.44 crores towards the objects Prospectus dated September 28, 2025 Whether all utilization is as per the disclosures in the Offer of the issue. Yes (Prospectus), CA Certificate*, Management No Comments Document? Utilisation Certificate and Bank statements Please also refer note on page 2 of the report Whether shareholder approval has been obtained in case of Prospectus dated September 28, 2025 material deviations# from expenditures disclosed in the Offer (Prospectus), CA Certificate*, Management Not A [Showing first 8,000 characters — download PDF for full document]